|
2024 Journal Article EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II—2024 update: treatment of relapsing and metastatic prostate cancerTilki, Derya, van den Bergh, Roderick C.N., Briers, Erik, Van den Broeck, Thomas, Brunckhorst, Oliver, Darraugh, Julie, Eberli, Daniel, De Meerleer, Gert, De Santis, Maria, Farolfi, Andrea, Gandaglia, Giorgio, Gillessen, Silke, Grivas, Nikolaos, Henry, Ann M., Lardas, Michael, J.L.H. van Leenders, Geert, Liew, Matthew, Linares Espinos, Estefania, Oldenburg, Jan, van Oort, Inge M., Oprea-Lager, Daniela E., Ploussard, Guillaume, Roberts, Matthew J., Rouvière, Olivier, Schoots, Ivo G., Schouten, Natasha, Smith, Emma J., Stranne, Johan, Wiegel, Thomas ... Cornford, Philip (2024). EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II—2024 update: treatment of relapsing and metastatic prostate cancer. European Urology, 86 (2), 164-182. doi: 10.1016/j.eururo.2024.04.010 |
|
2023 Journal Article Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission tomographyVis, André N., Meijer, Dennie, Roberts, Matthew J., Siriwardana, Amila R., Morton, Andrew, Yaxley, John W., Samaratunga, Hemamali, Emmett, Louise, van de Ven, Peter M., Heymans, Martijn W., Nieuwenhuijzen, Jakko A., van der Poel, Henk G., Donswijk, Maarten L., Boellaard, Thierry N., Schoots, Ivo G., Stricker, Phillip, Haynes, Anne-Maree, Oprea-Lager, Daniela E., Coughlin, Geoffrey D. and van Leeuwen, Pim J. (2023). Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission tomography. European Urology Oncology, 6 (6), 553-563. doi: 10.1016/j.euo.2023.03.010 |
|
2023 Journal Article The effectiveness of a criteria-led discharge initiative on the length of stay of patients who underwent a robotic-assisted laparoscopic prostatectomySaad, Jeremy, Shanmugasundaram, Ramesh, Canagasingham, Bertram, Ferguson, Richard, Goolam, Ahmed, Khadra, Mohamed, Ko, Raymod, McCombie, Steve P., Reddy, Sumeet, Roberts, Matthew J., Thangasamy, Isaac, Varol, Celi, Zhong, Wenjie and Arianayagam, Mohan (2023). The effectiveness of a criteria-led discharge initiative on the length of stay of patients who underwent a robotic-assisted laparoscopic prostatectomy. Société Internationale d’Urologie Journal, 4 (6), 458-463. doi: 10.48083/plly8153 |
|
2023 Conference Publication Virtual healthcare delivery in urology - is AI the future for patient information on prostate cancer?Collin, Harry and Roberts, Matthew (2023). Virtual healthcare delivery in urology - is AI the future for patient information on prostate cancer?. Annual Scientific Meeting of the Singapore-Urological-Association (SUA), Singapore, 6-8 July 2023. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. |
|
2023 Conference Publication Quality of health information in ChatGPT responses to common patient enquiries about recurrent UTI treatment and preventionCollin, Harry and Roberts, Matthew (2023). Quality of health information in ChatGPT responses to common patient enquiries about recurrent UTI treatment and prevention. Annual Scientific Meeting of the Singapore-Urological-Association (SUA), Singapore, 6-8 July 2023. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. |
|
2023 Journal Article 68Ga-PSMA-PET/CT in addition to mpMRI in men undergoing biopsy during active surveillance for low- to intermediate-risk prostate cancer: study protocol for a prospective cross-sectional studyGondoputro, William, Doan, Paul, Katelaris, Athos, Scheltema, Matthijs J., Geboers, Bart, Agrawal, Shikha, Liu, Zhixin, Yaxley, John, Savdie, Richard, Rasiah, Kris, Frydenberg, Mark, Roberts, Matthew J., Malouf, David, Wong, David, Shnier, Ron, Delprado, Warick, Emmett, Louise, Stricker, Phillip D. and Thompson, James (2023). 68Ga-PSMA-PET/CT in addition to mpMRI in men undergoing biopsy during active surveillance for low- to intermediate-risk prostate cancer: study protocol for a prospective cross-sectional study. Translational Andrology and Urology, 12 (10), 1598-1606. doi: 10.21037/tau-22-708 |
|
2023 Journal Article Prostate volume analysis in image registration for prostate cancer care: a verification studyBugeja, Jessica M., Mehawed, Georges, Roberts, Matthew J., Rukin, Nicholas, Dowling, Jason and Murray, Rebecca (2023). Prostate volume analysis in image registration for prostate cancer care: a verification study. Physical and Engineering Sciences in Medicine, 46 (4), 1-12. doi: 10.1007/s13246-023-01342-4 |
|
2023 Journal Article High risk clear cell renal cell carcinoma microenvironments contain protumour immunophenotypes lacking specific immune checkpointsRaghubar, Arti M., Matigian, Nicholas A., Crawford, Joanna, Francis, Leo, Ellis, Robert, Healy, Helen G., Kassianos, Andrew J., Ng, Monica S. Y., Roberts, Matthew J., Wood, Simon and Mallett, Andrew J. (2023). High risk clear cell renal cell carcinoma microenvironments contain protumour immunophenotypes lacking specific immune checkpoints. npj Precision Oncology, 7 (1) 88, 1-9. doi: 10.1038/s41698-023-00441-5 |
|
2023 Journal Article DIPPER trial protocol: A multi‐centre, randomised trial of salvage radiotherapy versus surveillance for biochemical recurrence after radical prostatectomy (ANZUP 2002)Roberts, Matthew J., Conduit, Ciara, Davis, Ian D., Effeney, Rachel M., Williams, Scott, Martin, Jarad M., Hofman, Michael S., Hruby, George, Eapen, Renu, Gianacas, Chris, Papa, Nathan, Lourenço, Richard De Abreu, Dhillon, Haryana M, Allen, Ray, Fontela, Antoinette, Kaur, Baldeep, Emmett, Louise and The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) (2023). DIPPER trial protocol: A multi‐centre, randomised trial of salvage radiotherapy versus surveillance for biochemical recurrence after radical prostatectomy (ANZUP 2002). BJU International, 133 (S3), 39-47. doi: 10.1111/bju.16158 |
|
2023 Journal Article Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma managementPathmanathan, Shivanshan, Tariq, Arsalan, Pearce, Adam, Rhee, Handoo, Kyle, Samuel, Raveenthiran, Sheliyan, Wong, David, McBean, Rhiannon, Marsh, Phillip, Goodman, Steven, Dhiantravan, Nattakorn, Esler, Rachel, Dunglison, Nigel, Navaratnam, Anojan, Yaxley, John, Thomas, Paul, Pattison, David A., Goh, Jeffrey C., Gan, Chun Loo and Roberts, Matthew J. (2023). Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management. European Journal of Nuclear Medicine and Molecular Imaging, 51 (1), 295-303. doi: 10.1007/s00259-023-06380-4 |
|
2023 Journal Article Uro-symphyseal fistula: a systematic review to inform a contemporary, evidence-based management frameworkPatel, Nishal, Mehawed, Georges, Dunglison, Nigel, Esler, Rachel, Navaratnam, Anojan, Yaxley, John, Chung, Eric, Tse, Vincent and Roberts, Matthew J. (2023). Uro-symphyseal fistula: a systematic review to inform a contemporary, evidence-based management framework. Urology, 178, 1-8. doi: 10.1016/j.urology.2023.05.002 |
|
2023 Conference Publication Dr Bot - Does AI provide quality information to prostate cancer patients?Collin, Harry, Keogh, Kandice and Roberts, Matthew (2023). Dr Bot - Does AI provide quality information to prostate cancer patients?. 2023 ANZUP Annual Scientific Meeting, Bouncing Back, Melbourne, VIC, Australia, 9-11 July 2023. Hoboken, NJ, United States: Wiley. |
|
2023 Journal Article Trends and variation in prostate cancer diagnosis via transperineal biopsy in Australia and New ZealandO' Callaghan, Michael E., Roberts, Matthew, Grummet, Jeremy, Mark, Stephen, Gilbourd, Daniel, Frydenberg, Mark, Millar, Jeremy and Papa, Nathan (2023). Trends and variation in prostate cancer diagnosis via transperineal biopsy in Australia and New Zealand. Urologic Oncology: Seminars and Original Investigations, 41 (7), 324.e13-324.e20. doi: 10.1016/j.urolonc.2023.05.011 |
|
2023 Conference Publication Initial diagnostic accuracy of FDG-PET compared to PSMA-PET for newly diagnosed high risk prostate cancer prior to treatment: FIND TrialRoberts, Matthew, Roberts, Natasha, Harley, Simon, Cullen, Karla, Pelecanos, Anita, Vela, Ian, Yaxley, John, Kuchel, Anna, Dhiantravan, Nattakorn, Thomas, Paul and Pattison, David (2023). Initial diagnostic accuracy of FDG-PET compared to PSMA-PET for newly diagnosed high risk prostate cancer prior to treatment: FIND Trial. 2023 ANZUP Annual Scientific Meeting, Bouncing Back, Melbourne, VIC, Australia, 9-11 July 2023. Hoboken, NJ, United States: Wiley. |
|
2023 Journal Article A novel risk calculator incorporating clinical parameters, multiparametric magnetic resonance imaging, and prostate-specific membrane antigen positron emission tomography for prostate cancer risk stratification before transperineal prostate biopsyKelly, Brian D., Ptasznik, Gideon, Roberts, Matthew J., Doan, Paul, Stricker, Phillip, Thompson, James, Buteau, James, Chen, Kenneth, Alghazo, Omar, O'Brien, Jonathan S., Hofman, Michael S., Frydenberg, Mark, Lawrentschuk, Nathan, Lundon, Dara, Murphy, Declan G., Emmett, Louise and Moon, Daniel (2023). A novel risk calculator incorporating clinical parameters, multiparametric magnetic resonance imaging, and prostate-specific membrane antigen positron emission tomography for prostate cancer risk stratification before transperineal prostate biopsy. European Urology Open Science, 53, 90-97. doi: 10.1016/j.euros.2023.05.002 |
|
2023 Conference Publication Lu-PSMA Therapy - Practical considerations for urologistsCollin, Harry, Keogh, Kandice and Roberts, Matthew (2023). Lu-PSMA Therapy - Practical considerations for urologists. 2023 ANZUP Annual Scientific Meeting, Bouncing Back, Melbourne, VIC, Australia, 9-11 July 2023. Hoboken, NJ, United States: Wiley. |
|
2023 Conference Publication PRIMARY2 Trial Protocol: Phase III, multicentre, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 PET/CT in men with negative/equivocal MRI in the diagnosis of clinically significant prostate cancerButeau, James, Moon, Daniel, Fahey, Michael, Roberts, Matthew, Thompson, James, Murphy, Declan G., Papa, Nathan, Mitchell, Catherine, Kasivisvanathan, Veeru, Stricker, Phillip, O'Brien, Jonathan, Counter, William, Sharma, Gaurav, Agrawal, Shikha, Ho, Bao, Dilulio, Juliana, Lindeman, William, De Abreu, Lourenco Richard, Dhillon, Haryana M., Hofman, Michael S. and Emmett, Louise (2023). PRIMARY2 Trial Protocol: Phase III, multicentre, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 PET/CT in men with negative/equivocal MRI in the diagnosis of clinically significant prostate cancer. 2023 ANZUP Annual Scientific Meeting, Bouncing Back, Melbourne, VIC, Australia, 9-11 July 2023. Hoboken, NJ, United States: Wiley. |
|
2023 Conference Publication Can artificial intelligence devise surveillance regimens for testicular cancer?Collin, Harry, Keogh, Kandice and Roberts, Matthew (2023). Can artificial intelligence devise surveillance regimens for testicular cancer?. 2023 ANZUP Annual Scientific Meeting, Bouncing Back, Melbourne, VIC, Australia, 9-11 July 2023. Hoboken, NJ, United States: Wiley. |
|
2023 Journal Article Vitamin C as an adjunct to methenamine hippurate use after ALTAR: ego or evidence‐based?Keogh, Kandice, Collin, Harry, Dowling, Caroline and Roberts, Matthew J. (2023). Vitamin C as an adjunct to methenamine hippurate use after ALTAR: ego or evidence‐based?. BJU International, 133 (S3), 6-7. doi: 10.1111/bju.16096 |
|
2023 Conference Publication Adding mitomycin (MM) to bacillus Calmette-Guerin (BCG) as adjuvant intravesical therapy for high-risk, non-muscle-invasive urothelial bladder cancer (NMIBC)Hayne, Dickon, Stockler, Martin R., Martin, Andrew James, McCombie, Steve P., Zebic, Danka Sinikovic, Bastick, Patricia A., Beardsley, Emma Kate, Frydenberg, Mark, Green, William, Grummet, Jeremy, Hawks, Cynthia, Ischia, Joseph, Mitterdorfer, Andrew, Patel, Manish, Roberts, Matthew, Sengupta, Shomik, Srivastav, Ratnesh Kumar, Redfern, Andrew David and Davis, Ian D. (2023). Adding mitomycin (MM) to bacillus Calmette-Guerin (BCG) as adjuvant intravesical therapy for high-risk, non-muscle-invasive urothelial bladder cancer (NMIBC). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL USA, 2-6 June 2023. Philadelphia, PA USA: Lippincott Williams & Wilkins. |
